Cargando…

The childhood immunization schedule and safety : stakeholder concerns, scientific evidence, and future studies /

"The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies reviews scientific findings and stakeholders concerns related to the safety of the recommended childhood immunization schedule. This report also identifies potential research approache...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, District of Columbia : National Academies Press, [2013]
Colección:Online access: NCBI NCBI Bookshelf.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn880439914
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 130724t20132013dcua ob 000 0 eng d
040 |a E7B  |b eng  |e rda  |e pn  |c E7B  |d OCLCO  |d YDXCP  |d N$T  |d COO  |d MMU  |d GPM  |d CUV  |d UCNAP  |d ORU  |d OCLCF  |d OCLCQ  |d EBLCP  |d OCLCQ  |d VT2  |d AGLDB  |d LIP  |d ZCU  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d BUF  |d OCLCO  |d OCL  |d OCLCO  |d STF  |d VNS  |d OCLCO  |d OCLCQ  |d VTS  |d EZ9  |d ICG  |d AU@  |d OCLCO  |d WYU  |d OCLCO  |d OCLCA  |d LVT  |d OCLCA  |d YDX  |d YDXIT  |d TKN  |d IHT  |d OCLCO  |d OCLCA  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCO  |d M8D  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d K6U  |d OCLCA  |d UKAHL  |d OCLCA  |d OCLCO  |d QGK  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
019 |a 830028300  |a 858096866  |a 929505332  |a 932320624  |a 961614705  |a 962666068  |a 990464799  |a 1021249775  |a 1028798952  |a 1048178635  |a 1055341913  |a 1065678743  |a 1081296135  |a 1156347077  |a 1204393160  |a 1228572841  |a 1229860356  |a 1249247021  |a 1259053228 
020 |a 9780309267038  |q (electronic book) 
020 |a 030926703X  |q (electronic book) 
020 |a 0309267056 
020 |a 9780309267052 
020 |z 9780309267021  |q (paperback) 
020 |z 0309267021  |q (paperback) 
029 1 |a DEBBG  |b BV042793434 
029 1 |a DEBBG  |b BV044184840 
029 1 |a DEBSZ  |b 42458574X 
035 |a (OCoLC)880439914  |z (OCoLC)830028300  |z (OCoLC)858096866  |z (OCoLC)929505332  |z (OCoLC)932320624  |z (OCoLC)961614705  |z (OCoLC)962666068  |z (OCoLC)990464799  |z (OCoLC)1021249775  |z (OCoLC)1028798952  |z (OCoLC)1048178635  |z (OCoLC)1055341913  |z (OCoLC)1065678743  |z (OCoLC)1081296135  |z (OCoLC)1156347077  |z (OCoLC)1204393160  |z (OCoLC)1228572841  |z (OCoLC)1229860356  |z (OCoLC)1249247021  |z (OCoLC)1259053228 
043 |a n-us---  |a n------ 
050 4 |a RJ240  |b .C448 2013 
060 4 |a WS 135 
072 7 |a MED  |x 030000  |2 bisacsh 
072 7 |a MED  |x 076000  |2 bisacsh 
072 7 |a MED  |x 078000  |2 bisacsh 
082 0 4 |a 614.4/7083  |2 23 
049 |a UAMI 
245 0 4 |a The childhood immunization schedule and safety :  |b stakeholder concerns, scientific evidence, and future studies /  |c Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. 
264 1 |a Washington, District of Columbia :  |b National Academies Press,  |c [2013] 
264 4 |c ©2013 
300 |a 1 online resource (235 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
505 0 |a Introduction -- Determination of the immunization schedule -- Existing data sources and systems -- Stakeholder concerns related to the safety of the immunization schedule -- Review of scientific findings -- Methodological approaches to studying health outcomes associated with the current immunization schedule: options, feasibility, ethical issues, and priorities -- Conclusions and recommendations. 
520 |a "The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies reviews scientific findings and stakeholders concerns related to the safety of the recommended childhood immunization schedule. This report also identifies potential research approaches, methodologies and study designs that could inform this question, considering strengths, weaknesses as well as ethical and financial feasibility of each approach. This report draws on data from existing surveillance systems, such as the Vaccine Safety Datalink, could be used and offers the best means for ongoing research efforts regarding the safety of the schedule. In recognition of this, future federal research approaches should: collect and assess evidence regarding public confidence in and concerns about the entire childhood immunization schedule, with the goal to improve communication with health care professionals, and between health care professionals and the public regarding safety; standardize definitions of key elements of the schedule, and relevant health outcomes; establish research priorities on the basis of epidemiological evidence, biological plausibility, and feasibility; and continue to fund and support the Vaccine Safety Datalink project to study the safety of the recommended immunization schedule"--  |c Publisher's description 
546 |a English. 
588 0 |a Online resource; title from digital title page (viewed on December 04, 2018). 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Immunization of children  |x Standards  |z United States. 
650 0 |a Vaccination of children  |x Standards  |z United States. 
650 0 |a Accidents  |x Prevention. 
650 0 |a Immunotherapy. 
650 0 |a Accidents. 
650 0 |a Public health. 
650 0 |a National health services. 
650 0 |a Biological products  |x Therapeutic use. 
650 0 |a Therapeutics. 
650 0 |a Medical care. 
650 0 |a Infants. 
650 0 |a Immunization. 
650 0 |a Vaccination. 
650 0 |a Children. 
650 0 |a Vaccines. 
651 0 |a North America. 
650 0 |a Biologicals. 
650 0 |a Biological products. 
650 1 2 |a Immunization Schedule 
650 1 2 |a Immunization  |x standards 
650 2 |a Biological Products 
650 2 |a Age Groups 
650 2 |a Immunologic Techniques 
650 2 |a Primary Prevention 
650 2 |a Immunotherapy, Active 
650 2 |a Accident Prevention 
650 2 |a Communicable Disease Control 
650 2 |a Immunotherapy 
650 2 |a Investigative Techniques 
650 2 |a Immunomodulation 
650 2 |a Preventive Health Services 
650 2 |a Persons 
650 2 |a Public Health Practice 
650 2 |a Accidents 
650 2 |a Complex Mixtures 
650 2 |a Americas 
650 2 |a Public Health 
650 2 |a Analytical, Diagnostic and Therapeutic Techniques and Equipment 
650 2 |a Geographic Locations 
650 2 |a Health Services 
650 2 |a Named Groups 
650 2 |a Chemicals and Drugs 
650 2 |a Biological Therapy 
650 2 |a Health Care Facilities, Manpower, and Services 
650 2 |a Environment and Public Health 
650 2 |a Geographicals 
650 2 |a Therapeutics 
650 2 |a Delivery of Health Care 
650 2 |a Infant 
650 2 |a Immunization 
650 2 |a Vaccination 
650 2 |a Child 
650 2 |a Safety 
650 2 |a Vaccines 
650 2 |a Biological Factors 
650 2 2 |a Vaccination  |x standards 
650 2 2 |a Vaccines  |x standards 
650 2 2 |a Safety  |x standards 
651 2 |a United States 
651 2 |a North America 
650 2 |a Patient Care 
650 6 |a Enfants  |x Immunisation  |x Normes  |z États-Unis. 
650 6 |a Enfants  |x Vaccination  |x Normes  |z États-Unis. 
650 6 |a Accidents  |x Prévention. 
650 6 |a Immunothérapie. 
650 6 |a Accidents. 
650 6 |a Santé publique. 
650 6 |a Services de santé. 
650 6 |a Biothérapie. 
650 6 |a Thérapeutique. 
650 6 |a Prestation de soins. 
650 6 |a Nourrissons. 
650 6 |a Immunisation. 
650 6 |a Vaccination. 
650 6 |a Enfants. 
650 6 |a Vaccins. 
650 6 |a Produits biologiques. 
651 6 |a Amérique du Nord. 
650 6 |a Soins médicaux. 
650 6 |a Médicaments biologiques. 
650 7 |a accidents.  |2 aat 
650 7 |a public health.  |2 aat 
650 7 |a infants.  |2 aat 
650 7 |a children (people by age group)  |2 aat 
650 7 |a treating (health care function)  |2 aat 
650 7 |a MEDICAL  |x Forensic Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Preventive Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Public Health.  |2 bisacsh 
650 7 |a Vaccines  |2 fast 
650 7 |a Vaccination  |2 fast 
650 7 |a Therapeutics  |2 fast 
650 7 |a Public health  |2 fast 
650 7 |a National health services  |2 fast 
650 7 |a Medical care  |2 fast 
650 7 |a Infants  |2 fast 
650 7 |a Immunotherapy  |2 fast 
650 7 |a Immunization  |2 fast 
650 7 |a Children  |2 fast 
650 7 |a Biological products  |x Therapeutic use  |2 fast 
650 7 |a Accidents  |x Prevention  |2 fast 
650 7 |a Accidents  |2 fast 
650 7 |a Immunization of children  |x Standards  |2 fast 
651 7 |a North America  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJxRHKPqWyj6g89H9PwHmd 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
710 2 |a Institute of Medicine (U.S.).  |b Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule,  |e issuing body. 
710 2 |a Institute of Medicine (U.S.).  |b Board on Population Health and Public Health Practice,  |e issuing body. 
758 |i has work:  |a Childhood Immunization Schedule and Safety (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCYd7Q6whjqxPPkPxftkB3j  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Childhood immunization schedule and safety : stakeholder concerns, scientific evidence, and future studies.  |d Washington, District of Columbia : National Academies Press, [2013]  |h xv, 219 pages ; 23 cm  |z 9780309267021  |w (DLC) 10863770  |w (OCoLC)826855563 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3564289  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36617680 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36561323 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3564289 
938 |a ebrary  |b EBRY  |n ebr10863770 
938 |a EBSCOhost  |b EBSC  |n 867762 
938 |a YBP Library Services  |b YANK  |n 11864753 
994 |a 92  |b IZTAP